NEW YORK (Reuters Health) – Insulin can be safely and effectively used as a first-line treatment, in combination with metformin, in patients with newly diagnosed type 2 diabetes,…
NEW YORK (Reuters Health) – Hormone replacement therapy (HRT) with estrogen/progestin reduces the risk of colorectal cancer, but Israeli researchers have found that aspirin use and an active…
NEW YORK (Reuters Health) – The risk of venous thromboembolism (VTE) conferred by oral contraceptives appears to be lowest with the older standbys: contraceptives containing levonorgestrel, progestogen-only pills,…
NEW YORK (Reuters Health) – For patients at high risk for coronary disease who do not sufficiently adjust their cholesterol levels with a moderate dose of a statin,…
NEW YORK (Reuters Health) – Patients with high-risk esophageal varices treated with the beta-blocker carvedilol had lower rates of first bleeding episodes than patients treated with variceal band…
NEW YORK (Reuters Health) – Neoadjuvant hormonal therapy for prostate cancer may increase the risk of death in men with coronary artery disease-induced heart failure or myocardial infarction…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, discusses research findings on forced exercise for patients with Parkinson’s Disease. Summary 1. Based on research findings, Parkinson’s…
NEW YORK (Reuters Health) – Long-term, high-dose ursodeoxycholic acid (UDCA) should not be used for treatment of primary sclerosing cholangitis because of the increased risk of severe adverse…
NEW YORK (Reuters Health) – Because of their ability to prevent, reduce, and delay skeletal complications with multiple myeloma, bisphosphonates are an essential component of treatment for this…
NEW YORK (Reuters Health) – New guidelines released by the American Psychiatric Association and the American College of Obstetricians and Gynecologists indicate that antidepressants and psychotherapy are possible…